TIRZEPATIDE TRACKER
The private Zepbound tracker.
Record Zepbound injections, indication-specific dosage changes, weight entries, symptoms, and injection sites in one private log.
FEATURES FOR ZEPBOUND USERS
Everything you need to track Zepbound.
01
Current Zepbound initiation and indication-specific maintenance doses
02
Weight entries and milestones shown alongside dosage history
03
Visual injection site rotation map
04
Progress photo comparison in the app's local working data
05
No account, company-operated cloud sync, or server-side health database
ZEPBOUND DOSE SCHEDULE
Current Zepbound dosing by indication.
| Dose or branch | Label guidance |
|---|---|
| 2.5 mg once weekly | Treatment initiation for 4 weeks; not approved as a maintenance dosage |
| 5 mg once weekly | Beginning after the first 4 weeks |
| 2.5 mg increments | If needed, after at least 4 weeks on the current dose |
| Weight-reduction maintenance | 5 mg, 10 mg, or 15 mg once weekly |
| OSA maintenance | 10 mg or 15 mg once weekly |
| Maximum for all indications | 15 mg once weekly |
Intermediate strengths can be used during escalation but are not among the label's maintenance choices. Maintenance selection depends on indication, response, and tolerability.
Source: current prescribing information for Zepbound.
This schedule is for informational purposes only. Always follow your healthcare provider's instructions for dosing and titration. Do not adjust your dose without medical guidance.
PRIVACY FIRST
Your Zepbound data is nobody's business.
No accounts
No email, no password, no sign-up.
Local working data
Working health data is kept locally in the app via SwiftData.
No company health sync
There is no company-operated cloud sync or server-side health database.
Apple backups are optional
An encrypted device backup may include app data, depending on your Apple and device settings.
FAQ
Zepbound tracking questions.
The app can record Zepbound's labeled strengths without calling each one a maintenance dose. The current label uses 2.5 mg for initiation only; weight-reduction maintenance doses are 5 mg, 10 mg, or 15 mg, while OSA maintenance doses are 10 mg or 15 mg.
Yes. The app presents recorded weight entries, dose-change markers, milestones, and progress photos together. It does not determine whether a particular dose caused a change.
Both contain tirzepatide, but their labeled indications and maintenance guidance differ. Zepbound is labeled for long-term weight reduction in specified adults and for moderate to severe OSA in adults with obesity; Mounjaro is labeled for type 2 diabetes in adults and pediatric patients aged 10 years and older.
Start tracking your Zepbound journey.
Private and simple, with local working data and no account required.
App Store download — No account required — No company-operated health-data sync